Janssen Kaylynn Callister HR Leader Oncology, Janssen Diagnostics, - PowerPoint PPT Presentation

Janssen Kaylynn Callister HR Leader Oncology, Janssen Diagnostics, Discovery Sciences

Today’s Agenda Goal is to help you become aware of what we do; who we are; and what we believe in • Introductions • Intro to J&J and Janssen • Panel of PhD employees • Q&A and Networking 2

Our History What year was Johnson & Johnson founded? Dr. Joseph Lister New Hire Toolkit | Slides Effective February, 2016 | Confidential | 3

• https://www.youtube.com/watch?v=r4-5OrdtXpI 4 New Hire Toolkit | Slides Effective February, 2016 | Confidential | 4

Our Credo Drives Our Success “I am resolute in my determination to keep Our Credo as the foundation of Johnson & Johnson. Our Credo has long been – and must continue to be – the defining feature of our organization, because it reflects our core value system, our beliefs and our aspirations.” –Alex Gorsky 5 New Hire Toolkit | Slides Effective February, 2016 | Confidential | 5

6 New Hire Toolkit | Slides Effective February, 2016 | Confidential | 6

About the Company BUSINESS STRUCTURE Consumer Pharmaceuticals Medical Devices New Hire Toolkit | Slides Effective February, 2016 | Confidential | 7

About the Company BUSINESS STRUCTURE – SEGMENTS Consumer – Products marketed to the general public and sold both to retail outlets and distributors. — Pharmaceuticals – Products distributed directly to retailers, wholesalers, and health care professionals — for prescription use. Medical Devices – Products distributed to wholesalers, hospitals, and retailers used principally in the — professional field by physicians, nurses, therapists, hospitals, diagnostic laboratories, and clinics. Medical Devices Consumer Pharmaceuticals § Therapeutic Areas § Vision Care/ Diabetes § Baby § Immunology § Global Surgery § Skin Care § Neuroscience § Surgical Care § Oral care § Infectious Diseases/ § Specialty Surgery § Women’s Health Vaccines § Infection Prevention § Wound Care § Oncology § Cardiovascular Care § OTC/Nutritionals § Cardiovascular & § Global Orthopedics Metabolism/Other § Diagnostics Confidential | 8 New Hire Toolkit | Slides Effective February, 2016 |

What are some of the original drug discoveries Dr. Paul Janssen made? 9

10

11

Janssen – Creating Value Through Innovation • Leader in productivity, FDA approvals, breakthrough designations • 14 new products since 2009 • Most FDA approvals 2009-2014 • One of the fastest growing top-ten pharmaceutical companies • Most admired pharmaceutical company 12

13

14

15

16

17

Huge Medical Need $28.1B +12.0% 18

19

20

21

22

23

24

2 25 5

Introduction to our Panel 3-4pm 4-5pm Q&A Networking Name Title Department Email Naushad Islam Sr. Director, Global Global Regulatory nislam@its.jnj.com Regulatory Organization Anne Vosatka VP, Compound Cardiovascular & avosatka@its.jnj.com Development Team Metabolics Leader John Fastenau Team Leader, Real Real World jfastena@its.jnj.com World Evidence Evidence Daniel Weinstock Sr. Director, Janssen dweinsto@its.jnj.com Immunopathology Biotherapeutics Toxicology Homer Adams Sr. Scientist Oncology hadamsii@its.jnj.com Brent Rupnow Director, Prostate Oncology brupnow@its.jnj.com Discovery Nishan Sengupta Global Market Access Oncology nsengupt@its.jnj.com Leader Doris Forestal Director, TA Head Oncology/CVM dforesta@its.jnj.com Global Labeling Oncology/CVM 26 Samantha Allen Sr. Scientist Screening sallen37@its.jnj.com